Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,871 total articles

Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Outlook Therapeutics reported its fiscal Q2 2026 financial results, highlighting a net loss reduction compared to last year and progress in commercializing LYTENAVA™ (bevacizumab gamma) in Europe including a new partnership in Switzerland. The company completed a formal dispute resolution meeting with the FDA regarding its U.S. approval application…

Cerebras Systems Announces Closing of Initial Public Offering

Cerebras Systems Announces Closing of Initial Public Offering

Cerebras Systems Inc. has completed its initial public offering of 34.5 million Class A common shares at $185 each, raising approximately $6.38 billion in gross proceeds. The company's stock began trading on Nasdaq under the ticker CBRS. Cerebras specializes in AI infrastructure with its flagship Wafer-Scale Engine 3 processor, which is significant…

Solana Company Reports First Quarter 2026 Financial Results

Solana Company Reports First Quarter 2026 Financial Results

Solana Company (NASDAQ: HSDT) reported Q1 2026 revenue of $3.6 million primarily from staking rewards, a substantial increase from the previous year. Despite strong gross profits, the company reported a net loss of $99.8 million due to large non-cash unrealized digital asset losses and operational expenses. The company continued capital allocation …

Binah Capital Group Reports Results for First Quarter of 2026

Binah Capital Group Reports Results for First Quarter of 2026

Binah Capital Group, Inc. announced its first quarter 2026 results marked by a 12.9% increase in assets under management to $29.0 billion, a near doubling of net income to $1.9 million, and a 50% increase in EBITDA compared to the prior year period. Despite stable total revenues around $48.7 million, the company achieved higher profitability and st…

Covenant Logistics Group Announces Quarterly Cash Dividend

Covenant Logistics Group Announces Quarterly Cash Dividend

Covenant Logistics Group, Inc. announced a quarterly cash dividend of $0.07 per share for both Class A and Class B common stock, payable on June 26, 2026, to shareholders of record as of June 5, 2026. The dividend distribution aligns with the company's approved cash dividend program, though future dividends remain subject to board approval and fina…

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Plus Therapeutics announced its first quarter 2026 financial results highlighting progress in its CNSide commercial expansion and REYOBIQ clinical development programs. The company secured FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas, expanded payer coverage for CNSide to approximately 81 million covered lives, and complet…

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

Candel Therapeutics reported extended phase 3 clinical trial results for its lead immunotherapy candidate, aglatimagene besadenovec (CAN-2409), in intermediate- to high-risk localized prostate cancer. After a median of 58 months follow-up, the therapy demonstrated a statistically significant 39% improvement in prostate cancer-specific disease-free …

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

Rani Therapeutics released its Q1 2026 financial results, highlighting progress in its Phase 1 clinical study of RT-114, an oral obesity treatment using its RaniPill® technology in collaboration with ProGen. The company appointed key strategic executives and announced a CFO transition while maintaining adequate cash to fund operations into late 202…

Hydrofarm Holdings Group Announces First Quarter 2026 Results

Hydrofarm Holdings Group Announces First Quarter 2026 Results

Hydrofarm Holdings Group, Inc. announced first quarter 2026 financial results with net sales down 29.6% year-over-year to $28.5 million, gross profit margin dropping to 6.4%, and a net loss of $14.6 million. The company is experiencing lower volume due to industry oversupply and has taken significant cost reduction measures including consolidating …

PDF Solutions® Announces Full Exercise of Greenshoe Option and Closing of Upsized Public Offering of Common Stock

PDF Solutions® Announces Full Exercise of Greenshoe Option and Closing of Upsized Public Offering of Common Stock

PDF Solutions successfully closed an upsized underwritten public offering of 5.25 million shares at $44.00 per share, including the full exercise of the underwriters' greenshoe option. The company raised approximately $85.7 million in gross proceeds, strengthening its capital base to support ongoing growth in semiconductor data solutions.

MacKenzie Realty Capital Reports Third Quarter 2026 Financial Results and Stabilization of Development

MacKenzie Realty Capital Reports Third Quarter 2026 Financial Results and Stabilization of Development

MacKenzie Realty Capital, Inc. announced its Q3 2026 financial results, showing significant improvement with a 27% increase in net revenues to $5.4 million and a return to positive funds from operations (FFO) of $308,040 compared to negative $3.2 million in the prior year. The company's Aurora at Green Valley development is now stabilized with over…

Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair

Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair

Regeneron Pharmaceuticals, Inc. sponsored the 2026 Regeneron International Science and Engineering Fair (ISEF), awarding over $7 million to high school students worldwide for innovative STEM projects. Hikaru Kuribayashi won the $100,000 top innovator award for his work on a simulation program related to complex folding. Other winners focused on env…

Luda Technology Group Limited announces 2025 full year results

Luda Technology Group Limited announces 2025 full year results

Luda Technology Group Limited (NYSE: LUD), a manufacturer and trader of stainless steel and carbon steel flanges and fittings, announced the completion and filing of its 2025 annual report on Form 20-F with the U.S. Securities and Exchange Commission. The company provides audited financial statements and highlights its over 20 years of operation in…

Peer-Reviewed Research Is Redefining Weight Loss Program Standards

Peer-Reviewed Research Is Redefining Weight Loss Program Standards

Medifast Inc. highlights the scientific validity of its OPTAVIA weight loss program, supported by over 18 randomized controlled trials and numerous peer-reviewed studies. Their program emphasizes preservation of lean mass and reduction of visceral fat, with coaching significantly improving weight loss outcomes over self-guided efforts. This peer-re…

Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation

Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation

Medifast's OPTAVIA program, supported by peer-reviewed research including 18 randomized controlled trials, demonstrates that structured meal replacement plans combined with coaching significantly reduce visceral fat and preserve lean muscle mass, which are critical for metabolic health. Clinical data highlights that coaching leads to substantially …

Alpha Modus Secures Patent Settlement with Adroit Worldwide Media, Advancing Multi-Jurisdictional IP Monetization

Alpha Modus Secures Patent Settlement with Adroit Worldwide Media, Advancing Multi-Jurisdictional IP Monetization

Alpha Modus Holdings, Inc. announced the resolution of its patent infringement lawsuit against Adroit Worldwide Media in the US District Court for the Central District of California. This settlement is part of Alpha Modus's broader patent enforcement campaign targeting real-time consumer behavior and retail media technology. The company emphasized …

Toll Brothers Announces Everstead, A New Luxury Townhome Community Coming Soon to Cary, North Carolina

Toll Brothers Announces Everstead, A New Luxury Townhome Community Coming Soon to Cary, North Carolina

Toll Brothers, a leading US luxury home builder, announced Everstead, a new luxury townhome community in Cary, North Carolina. Featuring spacious, modern townhomes with personalization options, the community targets buyers seeking low-maintenance luxury living close to top schools and major employment hubs like Research Triangle Park. Sales are ant…

Scripps completes station swap with Gray Media

Scripps completes station swap with Gray Media

The E.W. Scripps Company has concluded a strategic local TV station swap with Gray Media involving five stations across mid-sized and small markets. The agreement expands Scripps' footprint notably in Colorado Springs, Twin Falls, and Grand Junction, enhancing its regional presence in the Mountain West. No cash was exchanged as the deal involved an…